Helius Medical Technologies Stock Performance
| HSDT Stock | USD 1.93 0.29 13.06% |
The company retains a Market Volatility (i.e., Beta) of 1.91, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Helius Medical will likely underperform. At this point, Helius Medical Techn has a negative expected return of -1.47%. Please make sure to check out Helius Medical's information ratio, potential upside, as well as the relationship between the Potential Upside and rate of daily change , to decide if Helius Medical Techn performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Helius Medical Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Last Split Factor 1:50 | Dividend Date 2021-01-04 | Last Split Date 2025-07-01 |
1 | Clear Streets Disruptive Technology Conference Convenes this Month in Palm Beach | 11/07/2025 |
2 | Can Helius Medical Technologies Inc. stock sustain free cash flow growth - 2025 Retail Activity Precise Swing Trade Entry Alerts - newser.com | 11/11/2025 |
3 | Solana Company Announces Intent to Tokenize HSDT Shares on Superstates Opening Bell | 11/12/2025 |
4 | What to Expect from Helius Medical Techs Earnings | 11/17/2025 |
5 | Solana Issues Earnings Results, Beats Estimates By 17.61 EPS | 11/19/2025 |
6 | Acquisition by Dane Andreeff of 1658 shares of Helius Medical at 7.6423 subject to Rule 16b-3 | 12/04/2025 |
7 | Why Helius Medical Technologies Inc. stock remains on buy lists - Chart Signals Weekly High Return Opportunities - DonanmHaber | 12/19/2025 |
8 | Income Plays Is Helius Medical Technologies Inc stock undervalued vs historical averages - Weekly Profit Summary Stock Portfolio Risk Control - moha.gov.vn | 01/08/2026 |
9 | Acquisition by Dane Andreeff of 30841 shares of Helius Medical at 0.3117 subject to Rule 16b-3 | 01/22/2026 |
| Begin Period Cash Flow | 5.2 M | |
| Total Cashflows From Investing Activities | -5000.00 |
Helius Medical Relative Risk vs. Return Landscape
If you would invest 538.00 in Helius Medical Technologies on November 8, 2025 and sell it today you would lose (345.00) from holding Helius Medical Technologies or give up 64.13% of portfolio value over 90 days. Helius Medical Technologies is currently does not generate positive expected returns and assumes 6.7993% risk (volatility on return distribution) over the 90 days horizon. In different words, 61% of stocks are less volatile than Helius, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Helius Medical Target Price Odds to finish over Current Price
The tendency of Helius Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.93 | 90 days | 1.93 | roughly 97.0 |
Based on a normal probability distribution, the odds of Helius Medical to move above the current price in 90 days from now is roughly 97.0 (This Helius Medical Technologies probability density function shows the probability of Helius Stock to fall within a particular range of prices over 90 days) .
Helius Medical Price Density |
| Price |
Predictive Modules for Helius Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Helius Medical Techn. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Helius Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Helius Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Helius Medical is not an exception. The market had few large corrections towards the Helius Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Helius Medical Technologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Helius Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.52 | |
β | Beta against Dow Jones | 1.91 | |
σ | Overall volatility | 0.89 | |
Ir | Information ratio | -0.21 |
Helius Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Helius Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Helius Medical Techn can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Helius Medical Techn generated a negative expected return over the last 90 days | |
| Helius Medical Techn has high historical volatility and very poor performance | |
| Helius Medical Techn may become a speculative penny stock | |
| The company reported the previous year's revenue of 520 K. Net Loss for the year was (11.74 M) with profit before overhead, payroll, taxes, and interest of 467 K. | |
| Helius Medical Technologies currently holds about 3.27 M in cash with (11.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 27.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Dane Andreeff of 30841 shares of Helius Medical at 0.3117 subject to Rule 16b-3 |
Helius Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Helius Stock often depends not only on the future outlook of the current and potential Helius Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Helius Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3613.04 | |
| Cash And Short Term Investments | 1.1 M |
Helius Medical Fundamentals Growth
Helius Stock prices reflect investors' perceptions of the future prospects and financial health of Helius Medical, and Helius Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Helius Stock performance.
| Return On Equity | -3.44 | ||||
| Return On Asset | -0.0399 | ||||
| Operating Margin | (7.04) % | ||||
| Current Valuation | 101.76 M | ||||
| Shares Outstanding | 41.3 M | ||||
| Price To Earning | (13.85) X | ||||
| Price To Book | 109.75 X | ||||
| Price To Sales | 97.44 X | ||||
| Revenue | 520 K | ||||
| Gross Profit | 467 K | ||||
| EBITDA | (13.8 M) | ||||
| Net Income | (11.74 M) | ||||
| Cash And Equivalents | 3.27 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 12 K | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 2.85 X | ||||
| Book Value Per Share | (3.78) X | ||||
| Cash Flow From Operations | (11.04 M) | ||||
| Earnings Per Share | (790.65) X | ||||
| Market Capitalization | 91.69 M | ||||
| Total Asset | 3.54 M | ||||
| Retained Earnings | (171.7 M) | ||||
| Working Capital | 1.26 M | ||||
| Current Asset | 6.8 M | ||||
| Current Liabilities | 4.46 M | ||||
About Helius Medical Performance
Assessing Helius Medical's fundamental ratios provides investors with valuable insights into Helius Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Helius Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 786.85 | 765.56 | |
| Return On Tangible Assets | (2.98) | (3.13) | |
| Return On Capital Employed | (9.07) | (9.53) | |
| Return On Assets | (2.98) | (3.13) | |
| Return On Equity | (12.75) | (12.11) |
Things to note about Helius Medical Techn performance evaluation
Checking the ongoing alerts about Helius Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Helius Medical Techn help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Helius Medical Techn generated a negative expected return over the last 90 days | |
| Helius Medical Techn has high historical volatility and very poor performance | |
| Helius Medical Techn may become a speculative penny stock | |
| The company reported the previous year's revenue of 520 K. Net Loss for the year was (11.74 M) with profit before overhead, payroll, taxes, and interest of 467 K. | |
| Helius Medical Technologies currently holds about 3.27 M in cash with (11.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 27.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Dane Andreeff of 30841 shares of Helius Medical at 0.3117 subject to Rule 16b-3 |
- Analyzing Helius Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Helius Medical's stock is overvalued or undervalued compared to its peers.
- Examining Helius Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Helius Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Helius Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Helius Medical's stock. These opinions can provide insight into Helius Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Helius Stock Analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.